Peptide derived from FGF2 or API5 and its use

Item Number: 638
Industry: Therapeutic
Category: Oncology
Development Stage: Early Stage
Organisation Type: Government Institute
Country: South Korea
Patent: Korea
Business Opportunity: Technology Transfer, Collaboration R&D


The present invention relates to synthetic peptide containing the amino-acid sequence derived from apoptosis inhibitor 5 (API5) and fibroblast growth factor 2 (FGF2). More particularly, it includes a method for screening for material to reduce anticancer drug resistance using the above synthetic peptide.

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it